Parvin Aminolroaya is an emerging leader within the Plaintiffs’ bar where she represents plaintiffs in mass tort and class action cases. She litigates product liability and class action cases and prepares them for trial.
Aminolroaya was appointed co-lead counsel in the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, consolidating dozens of lawsuits against drugmakers Novo Nordisk and Eli Lilly filed by patients who took Ozempic and other similar GLP-1 RA medications and suffered serious injuries.
Lawdragon Honors
Aminolroaya serves as co-lead counsel in the Elmiron Products Liability litigation, a nationwide multi-district litigation against numerous pharmaceutical companies, including Janssen, alleging that the companies failed to tell doctors and patients about the risk of permanent vision injury with the drug Elmiron. In the Testosterone Replacement Therapy Products Liability Litigation, where it was alleged that Androgel caused heart attacks and strokes in users, she worked on multiple bellwether trial teams and was responsible for presenting a key FDA regulatory expert in a trial that resulted in an initial verdict of $140 million for the plaintiff. A series of bellwether trials in that litigation resulted in more than $290 million in initial verdicts. Aminolroaya also worked on the 3M Earplug litigation in which it was alleged that 3M knowingly marketed, manufactured, and sold dangerously defective earplugs. She prepared expert and fact witnesses for a bellwether trial that resulted in a $110M verdict against 3M.
In addition to her trial work, Aminolroaya also often leads the development of regulatory and scientific experts in pharmaceutical drug and device cases. In Elmiron, she led the development of multiple causation and liability experts. She has also co-led teams handling a key FDA expert for the nationwide Opioids MDL litigation and the Hernia Mesh MDL litigation.
Outside of her work on the above MDLs, Aminolroaya has played a role in such significant matters as:
- The nationwide litigation battle over opioid drugs, representing counties and municipalities whose health and hospital systems have been severely tested by the epidemic of drug abuse. The opioid lawsuits are “on par to become the largest civil litigation agreement in U.S. history,” according to Forbes Magazine;
- The multi-billion-dollar cases brought against Volkswagen and other carmakers for disguising the actual emission levels of their diesel engine cars. The settlement figure in this case makes it “the largest auto-related consumer class-action settlement in U.S. history,” lawyers told The Star of Toronto.
- Representing many investors in Bernard Madoff’s investment fund, revealed to be a billion-dollar Ponzi scheme, and protecting the investors’ millions of dollars when the court-appointed bankruptcy trustee attempted to take back money they had in good faith withdrawn from their Madoff accounts. The U.S. Attorney’s office in New York indicated in proceedings that the Madoff Ponzi scheme was the largest in history, and the largest investor fraud ever committed by a single person.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
